Miyako Capital logo

Miyako Capital

Asia, Kyoto, Japan, Kyoto

Description

Venture capital that manages Kyoto University 2nd Venture Fund (KUVF).

Investor Profile

Miyako Capital has backed more than 14 startups, with 4 new investments in the last 12 months alone. The firm has led 3 rounds, about 21% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series C, Series A rounds (top funding stages).
  • Majority of deals are located in Japan, United States, United Kingdom.
  • Strong thematic focus on Information Technology, Artificial Intelligence (AI), Biotechnology.

Stage Focus

  • Seed (43%)
  • Series C (29%)
  • Series A (21%)
  • Series B (7%)

Country Focus

  • Japan (71%)
  • United States (21%)
  • United Kingdom (7%)

Industry Focus

  • Information Technology
  • Artificial Intelligence (Ai)
  • Biotechnology
  • Medical
  • Health Care
  • Software
  • Generative Ai
  • Semiconductor
  • Machine Learning
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Miyako Capital frequently co-invest with?

Basis Set Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
SMBC Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
ANRI
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Global Brain Corporation
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3
Mizuho Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
500 Global
North America, California, United States, San Francisco
Co-Investments: 2
JAFCO
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
KDDI
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Lux Capital
North America, New York, United States, New York
Co-Investments: 2
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 2

Which angels does Miyako Capital often collaborate with?

JD
North America, California, United States, Palo Alto
Shared Deals: 1
CD
North America, New York, United States, New York
Shared Deals: 1
RH
North America, District of Columbia, United States, Washington
Shared Deals: 1

What are some of recent deals done by Miyako Capital?

Oishii

Jersey City, New Jersey, United States

Oishii is a vertical farming company that grows fruit in an indoor vertical farm at commercial scale.

AgricultureAgTechFarming
Series BDec 17, 2024
Amount Raised: $19,535,078
Peds3

Tokyo, Tokyo, Japan

Peds3 is a digital healthcare platform that specializes in the development of pediatric medicine and maternal and child health fields.

Child CareHealth CareMedical
SeedOct 2, 2024
Amount Raised: $750,451
Innovative Space Carrier

Tokyo, Tokyo, Japan

Innovative Space Carrier is a aerospace company that offers space transportation systems, planning, drafting and technology strategies.

AerospaceConsultingTransportation
SeedSep 10, 2024
Amount Raised: $2,531,162
Sakana AI

Tokyo, Tokyo, Japan

Sakana AI is an IT firm that develops an AI-based model to generate text, images, video, code, and multimedia.

Artificial Intelligence (AI)Generative AIInformation Technology
Series ASep 4, 2024
Amount Raised: $214,000,000
Orange

Akasaka, Tokyo, Japan

Orange is a developer of a variety of deep-learning models with a focus on computer vision and natural language processing for comics.

Artificial Intelligence (AI)Information TechnologyMachine Learning
SeedMay 6, 2024
Amount Raised: $18,975,394
Sakana AI

Tokyo, Tokyo, Japan

Sakana AI creates a new kind of foundation model based on nature-inspired intelligence.

Artificial Intelligence (AI)Generative AIInformation Technology
SeedJan 16, 2024
Amount Raised: $30,000,000
Helpfeel

Kyoto, Kyoto, Japan

Nota develops an app for seriously easy sharing of screen caps and GIFs and Scrapbox, a new style of note-taking for teams.

CollaborationDeveloper ToolsMobileMobile Apps
Series CSep 5, 2022
Amount Raised: $4,272,424
Viage Therapeutics

San Francisco, California, United States

Viage Therapeutics is a biotech company that develops therapeutics that stimulates the central nervous system via the gut-brain axis.

BiotechnologyClinical TrialsMedical
SeedJan 6, 2022
Amount Raised: $10,000,000
VividQ

Cambridge, Cambridgeshire, United Kingdom

VividQ has created the next generation of immersive experience through their computational holographic display technology.

3D TechnologyAugmented RealitySoftwareVirtual Reality
SeedJul 1, 2021
Amount Raised: $15,134,942
VLP Therapeutics

Gaithersburg, Maryland, United States

VLP is a biotech company with a mission to address unmet medical needs worldwide and expand the frontiers of vaccine treatment.

BiotechnologyHealth CareMedicalMedical Device
Series AMar 15, 2021
Amount Raised: $16,000,000